Citations (30)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Sreenivas Pandit, Erdal Cevher, Mohammed Gulrez Zariwala, Satyanarayana Somavarapu & H. Oya Alpar. (2007) Enhancement of immune response of HBsAg loaded poly (L-lactic acid) microspheres against Hepatitis B through incorporation of alum and chitosan. Journal of Microencapsulation 24:6, pages 539-552.
Read now
Read now
Karin Östh, Lena Strindelius, Agneta Larhed, Anders Ahlander, Godfried M. Roomans, Ingvar Sjöholm & Erik Björk. (2003) Uptake of Ovalbumin-conjugated Starch Microparticles by Pig Respiratory Nasal Mucosa In Vitro. Journal of Drug Targeting 11:1, pages 75-82.
Read now
Read now
J. Brooking, S. S. Davis & L. Illum. (2001) Transport of Nanoparticles Across the Rat Nasal Mucosa. Journal of Drug Targeting 9:4, pages 267-279.
Read now
Read now
A. J. Almeida & H. O. Alpar. (1996) Nasal Delivery of Vaccines. Journal of Drug Targeting 3:6, pages 455-467.
Read now
Read now
Articles from other publishers (26)
Kamonthip Rungrojcharoenkit, Panya Sunintaboon, Damon Ellison, Louis Macareo, Panuwat Midoeng, Preamrudee Chaisuwirat, Stefan Fernandez & Sukathida Ubol. (2020) Development of an adjuvanted nanoparticle vaccine against influenza virus, an in vitro study. PLOS ONE 15:8, pages e0237218.
Crossref
Crossref
Genada Sinani, Melike Sessevmez, M. Koray Gök, Saadet Özgümüş, Alper Okyar, H. Oya Alpar & Erdal Cevher. (2017) Nasal vaccination with poly(β-amino ester)-poly( d , l -lactide- co -glycolide) hybrid nanoparticles. International Journal of Pharmaceutics 529:1-2, pages 1-14.
Crossref
Crossref
Ajay Banga. 2015. Therapeutic Peptides and Proteins. Therapeutic Peptides and Proteins
301
338
.
Miguel A. Rodrigues, Lara Figueiredo, Lu?s Padrela, Ana Cadete, Jo?o Tiago, Henrique A. Matos, Edmundo Gomes de Azevedo, Helena F. Florindo, L?dia M.D. Gon?alves & Ant?nio J. Almeida. (2012) Development of a novel mucosal vaccine against strangles by supercritical enhanced atomization spray-drying of Streptococcus equi extracts and evaluation in a mouse model. European Journal of Pharmaceutics and Biopharmaceutics 82:2, pages 392-400.
Crossref
Crossref
António J. Almeida*Helena F. Florindo. 2012. Nanostructured Biomaterials for Overcoming Biological Barriers. Nanostructured Biomaterials for Overcoming Biological Barriers
117
132
.
Hideo Nakane. (2011) Translocation of particles deposited in the respiratory system: a systematic review and statistical analysis. Environmental Health and Preventive Medicine 17:4, pages 263-274.
Crossref
Crossref
Aihua Yu, Haigang Wang, Jiali Wang, Fengliang Cao, Yan Gao, Jing Cui & Guangxi Zhai. (2011) Formulation Optimization and Bioavailability After Oral and Nasal Administration in Rabbits of Puerarin-Loaded Microemulsion. Journal of Pharmaceutical Sciences 100:3, pages 933-941.
Crossref
Crossref
Dilip Pawar, Amit K. Goyal, Sharad Mangal, Neeraj Mishra, Bhuvaneshwar Vaidya, Shailja Tiwari, Arvind K. Jain & Suresh P. Vyas. (2010) Evaluation of Mucoadhesive PLGA Microparticles for Nasal Immunization. The AAPS Journal 12:2, pages 130-137.
Crossref
Crossref
J E Eyles, I D Spiers, E D Williamson & H O Alpar. (2001) Tissue distribution of radioactivity following intranasal administration of radioactive microspheres. Journal of Pharmacy and Pharmacology 53:5, pages 601-607.
Crossref
Crossref
Hiromitsu Yamamoto, Wataru Hoshina, Homare Kurashima, Hirofumi Takeuchi, Yoshiaki Kawashima, Toyokazu Yokoyama & Hiroyuki Tsujimoto. (2007) Engineering of poly(DL-lactic-co-glycolic acid) nanocomposite particles for dry powder inhalation dosage forms of insulin with the spray-fluidized bed granulating system. Advanced Powder Technology 18:2, pages 215-228.
Crossref
Crossref
Maryam Amidi, Stefan G. Romeijn, J. Coos Verhoef, Hans E. Junginger, Laura Bungener, Anke Huckriede, Daan J.A. Crommelin & Wim Jiskoot. (2007) N-Trimethyl chitosan (TMC) nanoparticles loaded with influenza subunit antigen for intranasal vaccination: Biological properties and immunogenicity in a mouse model. Vaccine 25:1, pages 144-153.
Crossref
Crossref
Yoshinori Fujimura, Takeshi Akisada, Tamotsu Harada & Ken Haruma. (2006) Uptake of microparticles into the epithelium of human nasopharyngeal lymphoid tissue. Medical Molecular Morphology 39:4, pages 181-186.
Crossref
Crossref
Michael Vajdy. (2006) Current Efforts on Generation of Optimal Immune Responses against HIV through Mucosal Immunisations. Drugs in R & D 7:5, pages 267-288.
Crossref
Crossref
Michael Vajdy, Indresh Srivastava, John Polo, John Donnelly, Derek O'Hagan & Manmohan Singh. (2004) Mucosal adjuvants and delivery systems for protein‐, DNA‐ and RNA‐based vaccines. Immunology & Cell Biology 82:6, pages 617-627.
Crossref
Crossref
Mark A. Jepson, M.Ann Clark & Barry H. Hirst. (2004) M cell targeting by lectins: a strategy for mucosal vaccination and drug delivery. Advanced Drug Delivery Reviews 56:4, pages 511-525.
Crossref
Crossref
Martin J Shephard, Daniel Todd, Brian M Adair, Alan Li Wan Po, Dermot P Mackie & Eileen M Scott. (2003) Immunogenicity of bovine parainfluenza type 3 virus proteins encapsulated in nanoparticle vaccines, following intranasal administration to mice. Research in Veterinary Science 74:2, pages 187-190.
Crossref
Crossref
I Gutierro, R.M Hernández, M Igartua, A.R Gascón & J.L Pedraz. (2002) Size dependent immune response after subcutaneous, oral and intranasal administration of BSA loaded nanospheres. Vaccine 21:1-2, pages 67-77.
Crossref
Crossref
M Christiane Schmidt, Annette Koch & Hans Merkle. 2002. Cell Culture Models of Biological Barriers. Cell Culture Models of Biological Barriers
228
252
.
J.E. Eyles, V.W. Bramwell, E.D. Williamson & H.O. Alpar. (2001) Microsphere translocation and immunopotentiation in systemic tissues following intranasal administration. Vaccine 19:32, pages 4732-4742.
Crossref
Crossref
Michael Vajdy & Derek T. O?Hagan. (2001) Microparticles for intranasal immunization. Advanced Drug Delivery Reviews 51:1-3, pages 127-141.
Crossref
Crossref
Jim E. Eyles, E. Diane Williamson & H. Oya Alpar. (2000) Intranasal Administration of Influenza Vaccines. BioDrugs 13:1, pages 35-59.
Crossref
Crossref
J.E Eyles, E.D Williamson, I.D Spiers, A.J Stagg, S.M Jones & H.O Alpar. (2000) Generation of protective immune responses to plague by mucosal administration of microsphere coencapsulated recombinant subunits. Journal of Controlled Release 63:1-2, pages 191-200.
Crossref
Crossref
Jim E Eyles, E.Diane Williamson & H.Oya Alpar. (1999) Immunological responses to nasal delivery of free and encapsulated tetanus toxoid: studies on the effect of vehicle volume. International Journal of Pharmaceutics 189:1, pages 75-79.
Crossref
Crossref
Jim E. Eyles, Ian D. Spiers, E. Diane Williamson & H. Oya Alpar. (1998) Analysis of local and systemic immunological responses after intra-tracheal, intra-nasal and intra-muscular administration of microsphere co-encapsulated Yersinia pestis sub-unit vaccines. Vaccine 16:20, pages 2000-2009.
Crossref
Crossref
Jim E. Eyles, Gregory J.E. Sharp, E. Diane Williamson, Ian D. Spiers & H. Oya Alpar. (1998) Intra nasal administration of poly-lactic acid microsphere co-encapsulated Yersinia pestis subunits confers protection from pneumonic plague in the mouse. Vaccine 16:7, pages 698-707.
Crossref
Crossref
Maureen D Donovan & Ye Huang. (1998) Large molecule and particulate uptake in the nasal cavity: the effect of size on nasal absorption. Advanced Drug Delivery Reviews 29:1-2, pages 147-155.
Crossref
Crossref